Fr. 238.00

Therapeutic Hypothermia

Inglese · Tascabile

Spedizione di solito entro 1 a 2 settimane (il titolo viene stampato sull'ordine)

Descrizione

Ulteriori informazioni

Samuel A. Tisherman, MD', Fritz Sterz, MD~ '~niversit~ of Pittsburgh, Pittsburgh, PA, USA 2~edical University of Vienna, Vienna, Austria The use of hypothermia for a variety of therapeutic purposes has a long and erratic history. Hippocrates recommended the use of topical cooling to stop bleeding. Fay used cooling of the extremities for patients with tumors in the 1930s. It wasn't until the 1950s, when the effects of hypothermia on systemic oxygen metabolism became better defined, that systemic hypothermia became a commonly used modality, particularly for cardiac surgery. Hypothermia was used for protection (treatment before the insult) and preservation (treatment during the insult) of the heart and entire organism during planned operative ischemia. Shortly thereafter, attempts were made to use hypothermia for resuscitation (treatment after the insult) from cardiac arrest and for management of head trauma. At that time, it was felt that moderate hypothermia (28-32OC) was needed. This was difficult to achieve and manage. Multiple complications were noted. Consequently, therapeutic, resuscitative hypothermia lay dormant for many years while mild (32-35°C) to moderate hypothermia became common for many cardiothoracic and neurosurgical procedures. In the early 1990s, it was found that mild hypothermia, even after cardiac arrest, had benefit for the brain. Similar results were found with head trauma. This lead to a burst of enthusiasm for research into resuscitative hypothermia for a variety of insults, most of which have tissue ischemia as a major component.

Sommario

Global Brain Ischemia: Animal Studies.- Global Cerebral Ischemia: Clinical Studies.- Focal Cerebral Ischemia: Mechanisms.- Focal Cerebral Ischemia: Clinical Studies.- Traumatic Brain Injury: Laboratory Studies.- Traumatic Brain Injury: Clinical Studies.- Spinal Cord Ischemia and Trauma.- Asphyxia.- Neonatal Asphyxia.- Hemorrhagic Shock and Exsanguination Cardiac Arrest.- Adult Respiratory Distress Syndrome and Sepsis.- Liver Failure and Intracerebral Hypertension.- Myocardial Ischemia and Infarction.- Cooling Methods.- Detrimental Effects of Hypothermia.- Future Directions.

Riassunto

Samuel A. Tisherman, MD', Fritz Sterz, MD~ '~niversit~ of Pittsburgh, Pittsburgh, PA, USA 2~edical University of Vienna, Vienna, Austria The use of hypothermia for a variety of therapeutic purposes has a long and erratic history. Hippocrates recommended the use of topical cooling to stop bleeding. Fay used cooling of the extremities for patients with tumors in the 1930s. It wasn't until the 1950s, when the effects of hypothermia on systemic oxygen metabolism became better defined, that systemic hypothermia became a commonly used modality, particularly for cardiac surgery. Hypothermia was used for protection (treatment before the insult) and preservation (treatment during the insult) of the heart and entire organism during planned operative ischemia. Shortly thereafter, attempts were made to use hypothermia for resuscitation (treatment after the insult) from cardiac arrest and for management of head trauma. At that time, it was felt that moderate hypothermia (28-32OC) was needed. This was difficult to achieve and manage. Multiple complications were noted. Consequently, therapeutic, resuscitative hypothermia lay dormant for many years while mild (32-35°C) to moderate hypothermia became common for many cardiothoracic and neurosurgical procedures. In the early 1990s, it was found that mild hypothermia, even after cardiac arrest, had benefit for the brain. Similar results were found with head trauma. This lead to a burst of enthusiasm for research into resuscitative hypothermia for a variety of insults, most of which have tissue ischemia as a major component.

Dettagli sul prodotto

Con la collaborazione di H Sterz (Editore), H Sterz (Editore), Fritz Sterz (Editore), Fritz H. Sterz (Editore), Samue Tisherman (Editore), Samuel Tisherman (Editore), Samuel A. Tisherman (Editore)
Editore Springer, Berlin
 
Lingue Inglese
Formato Tascabile
Pubblicazione 21.10.2010
 
EAN 9781441937933
ISBN 978-1-4419-3793-3
Pagine 258
Dimensioni 157 mm x 15 mm x 240 mm
Peso 416 g
Illustrazioni XIV, 258 p.
Serie Molecular & Cellular Biology of Critical Care Medicine
Molecular & Cellular Biology of Critical Care Medicine
Categorie Scienze naturali, medicina, informatica, tecnica > Medicina > Branche non cliniche

C, Medicine, critical care medicine, Intensive / Critical Care Medicine, Intensive Care Medicine

Recensioni dei clienti

Per questo articolo non c'è ancora nessuna recensione. Scrivi la prima recensione e aiuta gli altri utenti a scegliere.

Scrivi una recensione

Top o flop? Scrivi la tua recensione.

Per i messaggi a CeDe.ch si prega di utilizzare il modulo di contatto.

I campi contrassegnati da * sono obbligatori.

Inviando questo modulo si accetta la nostra dichiarazione protezione dati.